Zhang Xiao, Zhao Qing, Wang Tao, Long Qilin, Sun Yixin, Jiao Liqun, Gullerova Monika
Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; China International Neuroscience Institute (China-INI), Beijing 100053, China.
M.D. Program, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Ageing Res Rev. 2023 Dec;92:102137. doi: 10.1016/j.arr.2023.102137. Epub 2023 Nov 23.
Vascular aging is a major risk factor for age-related cardiovascular diseases, which have high rates of morbidity and mortality. It is characterized by changes in the blood vessels, such as macroscopically increased vascular diameter and intima-medial thickness, chronic inflammation, vascular calcification, arterial stiffening, and atherosclerosis. DNA damage and the subsequent various DNA damage response (DDR) pathways are important causative factors of vascular aging. Deficient DDR, which may result in the accumulation of unrepaired damaged DNA or mutations, can lead to vascular aging. On the other hand, over-activation of some DDR proteins, such as poly (ADP ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM), also can enhance the process of vascular aging, suggesting that DDR can have both positive and negative effects on vascular aging. Despite the evidence reviewed in this paper, the role of DDR in vascular aging and potential therapeutic targets remain poorly understood and require further investigation.
血管老化是与年龄相关的心血管疾病的主要危险因素,这类疾病具有很高的发病率和死亡率。其特征是血管发生变化,如宏观上血管直径增大和内膜中层厚度增加、慢性炎症、血管钙化、动脉僵硬以及动脉粥样硬化。DNA损伤及随后的各种DNA损伤反应(DDR)途径是血管老化的重要致病因素。DDR缺陷可能导致未修复的受损DNA积累或突变,进而引发血管老化。另一方面,一些DDR蛋白的过度激活,如聚(ADP核糖)聚合酶(PARP)和共济失调毛细血管扩张突变蛋白(ATM),也会加速血管老化进程,这表明DDR对血管老化可能具有正负两方面的影响。尽管本文综述了相关证据,但DDR在血管老化中的作用以及潜在的治疗靶点仍知之甚少,需要进一步研究。
Ageing Res Rev. 2023-12
World J Surg. 2009-4
J Natl Cancer Inst. 2017-11-1
J Exp Clin Cancer Res. 2013-11-19
MedComm (2020). 2025-9-1
Front Cardiovasc Med. 2025-2-18
Int J Parasitol Drugs Drug Resist. 2025-4